Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel T Wilkinson

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Psychiatric Services (Washington, D.C.)|February 2, 2018
Identifying Recipients of Electroconvulsive Therapy: Data From Privately Insured AmericansSamuel T Wilkinson, Edeanya Agbese, Douglas L Leslie, et al.
Women'S Health Reports (New Rochelle, N.Y.)|October 27, 2025
Real-World Outcomes of Brexanolone to Treat Postpartum DepressionMelanie Barrett, Jennifer Hettema, Constance Youngman, et al.
The Journal of Clinical Psychiatry|January 26, 2023
Effects of Electroconvulsive Therapy on Functional Outcomes Among Medicare Patients With Comorbid Depression and Dementia: A Nationwide 1-Year Follow-Up StudySamuel T Wilkinson, Kyaw Sint, Brent P Forester, et al.
Drug Discovery Today|November 4, 2023
Psychedelic renaissance: Revitalized potential therapies for psychiatric disordersTaeho Greg Rhee, Pasha A Davoudian, Gerard Sanacora, et al.
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Impact of cannabis use on health outcomes and prescription benzodiazepine useNirmal Singh, Yi Dai, Samuel T Wilkinson, et al.
The Journal of Clinical Psychiatry|May 7, 2026
Concurrent SSRI, SNRI, or Other Antidepressant Use Not Associated With Differential Outcomes in Ketamine or Esketamine TreatmentErin Curran, Morgan Hardy, Rachel Katz, et al.
The Journal of ECT|June 29, 2018
The Successful Use of Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and a Pituitary LesionBrandon M Kitay, Rachel B Katz, Samuel T Wilkinson, et al.
The Psychiatric Quarterly|May 19, 2015
The Formation of Marijuana Risk Perception in a Population of Substance Abusing PatientsSamuel T Wilkinson, Gerrit I van Schalkwyk, Larry Davidson, et al.
Fundamental & Clinical Pharmacology|June 11, 2026
Monitoring of Clinics That Use Direct-to-Consumer Advertising for Off-Label Ketamine in the New York Metropolitan Area: A Cross-Sectional Systematic Web SearchNina Abukahok, Steven Lawrence, Samrachana Adhikari, et al.
Annual Review of Medicine|October 31, 2015
Marijuana Legalization: Impact on Physicians and Public HealthSamuel T Wilkinson, Stephanie Yarnell, Rajiv Radhakrishnan, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Psychiatric Services (Washington, D.C.)|February 2, 2018
Identifying Recipients of Electroconvulsive Therapy: Data From Privately Insured AmericansSamuel T Wilkinson, Edeanya Agbese, Douglas L Leslie, et al.
Women'S Health Reports (New Rochelle, N.Y.)|October 27, 2025
Real-World Outcomes of Brexanolone to Treat Postpartum DepressionMelanie Barrett, Jennifer Hettema, Constance Youngman, et al.
The Journal of Clinical Psychiatry|January 26, 2023
Effects of Electroconvulsive Therapy on Functional Outcomes Among Medicare Patients With Comorbid Depression and Dementia: A Nationwide 1-Year Follow-Up StudySamuel T Wilkinson, Kyaw Sint, Brent P Forester, et al.
Drug Discovery Today|November 4, 2023
Psychedelic renaissance: Revitalized potential therapies for psychiatric disordersTaeho Greg Rhee, Pasha A Davoudian, Gerard Sanacora, et al.
Medrxiv : the Preprint Server for Health Sciences|September 5, 2025
Impact of cannabis use on health outcomes and prescription benzodiazepine useNirmal Singh, Yi Dai, Samuel T Wilkinson, et al.
The Journal of Clinical Psychiatry|May 7, 2026
Concurrent SSRI, SNRI, or Other Antidepressant Use Not Associated With Differential Outcomes in Ketamine or Esketamine TreatmentErin Curran, Morgan Hardy, Rachel Katz, et al.
The Journal of ECT|June 29, 2018
The Successful Use of Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and a Pituitary LesionBrandon M Kitay, Rachel B Katz, Samuel T Wilkinson, et al.
The Psychiatric Quarterly|May 19, 2015
The Formation of Marijuana Risk Perception in a Population of Substance Abusing PatientsSamuel T Wilkinson, Gerrit I van Schalkwyk, Larry Davidson, et al.
Fundamental & Clinical Pharmacology|June 11, 2026
Monitoring of Clinics That Use Direct-to-Consumer Advertising for Off-Label Ketamine in the New York Metropolitan Area: A Cross-Sectional Systematic Web SearchNina Abukahok, Steven Lawrence, Samrachana Adhikari, et al.
Annual Review of Medicine|October 31, 2015
Marijuana Legalization: Impact on Physicians and Public HealthSamuel T Wilkinson, Stephanie Yarnell, Rajiv Radhakrishnan, et al.
Pageof 11